image: Join us in Berlin on October 29-31, 2024, to learn more about the strategic role of mitochondria and its applications to accelerate therapies
Credit: World Mitochondria Society (WMS)
The World Mitochondria Society (WMS) is pleased to announce the program release of the 15th World Congress on Targeting Mitochondria, scheduled for October 29-31, 2024, in Berlin. This congress will gather international leaders in mitochondrial research to discuss advances in mitochondria research and their wide-ranging applications in health and disease treatment. Targeting Mitochondria 2024 will discuss breakthroughs in mitochondrial research and their potential clinical applications, marking a significant milestone in the journey towards more effective mitochondrial therapies.
Mitochondria, the energy powerhouses of the cell, are critical for cellular function and survival. Dysfunctional mitochondria are implicated in a variety of diseases, including neurodegenerative disorders, cardiovascular diseases, and metabolic conditions. The congress aims to highlight the revolutionary potential of mitochondria research in developing new therapeutic strategies and improving health outcomes.
Strategic Importance and Future Applications of Mitochondria Research
Research into mitochondria is rapidly becoming a foundation of innovative medical treatments. By elucidating the mechanisms of mitochondrial function and dysfunction, scientists are paving the way for novel therapies that address the root causes of many complex diseases. This congress will emphasize the strategic significance of mitochondria research in transforming medical science.
Mitochondria research is set to drive significant advances across multiple areas of healthcare:
- Neuroprotection and Cognitive Health: Understanding mitochondrial roles in neurodegeneration opens avenues for new treatments for diseases like Alzheimer's, Parkinson's, and multiple sclerosis. Protecting and enhancing mitochondrial function can improve cognitive health and delay the onset of neurodegenerative diseases.
- Cardiovascular Health: Mitochondria play a crucial role in heart function. Research into mitochondrial bioenergetics is leading to new therapies for heart failure, ischemic heart disease, and other cardiovascular conditions by improving energy production and reducing oxidative stress in cardiac cells.
- Metabolic Disorders: Mitochondria are central to metabolic regulation. Innovations in this field can lead to better treatments for diabetes, obesity, and related metabolic disorders by targeting mitochondrial pathways to improve energy balance and metabolic health.
- Anti-Aging and Longevity: Mitochondrial dysfunction is a hallmark of aging. Research in this area is presenting strategies to enhance mitochondrial function, potentially extending healthy lifespan and reducing age-related diseases.
- Cancer Therapy: Mitochondria are involved in cancer cell metabolism and apoptosis. Targeting mitochondrial pathways can lead to the development of new cancer treatments that selectively induce cancer cell death while sparing healthy cells.
- Infectious Diseases: Mitochondria play a role in the immune response to infections. Understanding this relationship can lead to improved treatments for infectious diseases and better management of chronic infections by enhancing mitochondrial function and immune defense mechanisms.
Targeting Mitochondria 2024 Speakers
Eric Schon, Columbia University, USA
Antentor Hinton, Vanderbilt University, USA
Naotada Ishihara, Osaka University
Ježek Petr, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Carsten Culmsee, University of Marburg, Germany
Sonia Levi, Vita-Salute San Raffaele University, Italy
Laurie Sanders, Duke University School of Medicine, USA
Egbert Mik, Erasmus MC, The Netherlands
Naïg Gueguen, CHU Angers, France
Giulia Bertolin, Université de Rennes, France
Stefano Pluchino, University of Cambridge, United Kingdom
Devika S Manickam, Duquesne University, USA
Howy Jacobs, Tampere University, Finland
Maik Hüttemann, Wayne State University, USA
Michael B. Powner, City University of London, United Kingdom
Stephen Tait, University of Glasgow, United Kingdom
Indira Mysorekar,Baylor College of Medicine, USA
Jonathan R. Brestoff, Washington University in St. Louis School of Medicine, USA
Mark Kindy, James A. Haley VA Hospital and University of South Florida, USA
Ana Andreazza, University of Toronto, Canada.
Jignesh D. Pandya, Walter Reed Army Institute of Research, USA
Elena Palma, King's College London, United Kingdom
For more information and to stay tuned with the latest updates on Targeting Mitochondria 2024, please visit: www.wms-site.com.
About World Mitochondria Society
The World Mitochondria Society, established in 2010, is dedicated to addressing the evolving challenges in mitochondrial research with a forward-thinking agenda. Under the leadership of President Volkmar Weissig and Founder Marvin Edeas, we prioritize Emerging Trends and Strategies to stimulate innovative discussions and explore new avenues in mitochondrial science.
Where to Find WMS?
LinkedIn Page | Facebook Page | Eurekalert Releases | Subscribe to our Newsletter.